Glycoprotein Ibα‐Dependent Platelet Activation is Essential for Tumor Cell–Platelet Interaction and Experimental Metastasis

Glycoprotein Ibα‐Dependent Platelet Activation is Essential for Tumor Cell–Platelet Interaction and Experimental Metastasis

ABSTRACT Metastasis is the main cause of cancer‐related deaths and the biggest challenge in improving cancer prognosis. Platelet–tumor cell aggregates are a prerequisite for hematogenous metastasis. However, the internal relation and molecular mechanism of platelets and their receptor glycoprotein (...

Full description

Saved in:
Bibliographic Details
Main Authors: Kangxi Zhou, Qing Li, Yue Xia, Chenglin Sun, Jing Wang, Yueyue Sun, Xinxin Ge, Mengnan Yang, Yu Li, Sai Zhang, Lili Zhao, Chunliang Liu, Khan Muhammad Shoaib, Weiling Xiao, Renping Hu, Kesheng Dai, Rong Yan
Format: Article
Language:English
Published: Wiley 2025-06-01
Series:MedComm
Subjects:
glycoprotein Ibα
metastasis
platelet activation
tumor cell–platelet interaction
Online Access:https://doi.org/10.1002/mco2.70217
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:ABSTRACT Metastasis is the main cause of cancer‐related deaths and the biggest challenge in improving cancer prognosis. Platelet–tumor cell aggregates are a prerequisite for hematogenous metastasis. However, the internal relation and molecular mechanism of platelets and their receptor glycoprotein (GP) Ibα in platelet–tumor cell interaction and metastasis remain elusive. Here, we find that in the absence of the full‐length GPIbα or its cytoplasmic tail, platelets maintain a more resting state and exhibit reduced tumor cell‐induced platelet activation. The deficiency of the cytoplasmic tail of GPIbα inhibits tumor cell–platelet interaction, platelet‐induced tumor cell migration and invasion, and metastasis. Using a state‐of‐the‐art spinning disk intravital microscopy, we observe a rapid accumulation of platelets on tumor cells, forming numerous tumor cell–platelet aggregates in vivo. We also find that the cytoplasmic tail of GPIbα regulates the tumor cell‐induced platelet protein kinase C‐α (PKCα) activation, and both the pharmacological inhibition and genetic ablation of platelet PKCα attenuate tumor cell‐induced platelet activation, tumor cell–platelet interaction, tumor cell migration and invasion, and metastasis. Overall, our findings reveal for the first time that GPIbα promotes experimental metastasis through its cytoplasmic tail‐regulated platelet activation, and suggest a potential target to regulate tumor hematogenous metastasis.
ISSN:2688-2663

Similar Items